💬In plain words
What the trial is, and whether it could suit you
The RH210A is an air-conduction hearing aid designed for adults with perceived mild-to-moderate sensorineural hearing loss. The purpose of this clinical investigation is to generate objective and subjective evidence of the clinical performance and safety of the device.
Sign in to get the eligibility rules as simple questions to take to your doctor.
📋 Eligibility rules (as published)
Inclusion Criteria:
* Age 18 years
* Self-perceived mild-to-moderate hearing difficulties/ hearing loss
* Competent smartphone use (able to complete self-fitting via the app)
* Able and willing to provide informed consent
* HHIA screening consistent with perceived hearing difficulty
* Willingness and ability to attend two in-person research appointments
* Ability to operate a SmartPhone
Exclusion Criteria:
* Conductive or mixed hearing loss
* Occluding cerumen
* Otologic disease/ active ear pathology
* Severe or profound hearing loss (PTA \>S0dBHL) (WHO, 2021)
* Presence of (red-flag) conditions relevant to OTC hearing aid use (per 21 CFR 801.421)
* Visible deformity of the ear (congenital or traumatic).
* Fluid, pus, or blood coming from the ear (e.g., active drainage).
* Sudden or rapidly progressive hearing loss within the recent past (often defined as within \~90 days).
* Any acute or chronic dizziness or vertigo associated with hearing issues.
* Pain or discomfort in or around the ear.
* Visible evidence of significant cerumen (ear wax) accumulation or foreign body in the ear canal.
* Unilateral hearing loss of sudden onset or large asymmetry between ears.
* Audiometric air-bone gap suggestive of possible conductive pathology (e.g., gap equal or more than 15 dB at key frequencies)
* Visible evidence of significant cerumen (ear wax) accumulation or foreign body in the ear canal.
* Unilateral hearing loss of sudden onset or large asymmetry between ears
HealthTeky